Comparison of Once Daily Fluticasone Furoate/Vilanterol With Twice Daily Fluticasone Propionate/Salmeterol in Patients With Controlled Asthma

被引：2
|
作者：
Bernstein, David
Forth, Richard
Yates, Louisa
Andersen, Leslie
Jacques, Loretta
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[2] Bernstein Clin Res Ctr, Cincinnati, OH USA
来源：
CHEST | 2017年 / 152卷 / 04期
关键词：
D O I：
10.1016/j.chest.2017.08.217
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：186A / 186A
页数：1
相关论文
共 50 条
  • [41] LONG-TERM EFFECTS OF ONCE-DAILY MOMETASONE FUROATE, TWICE-DAILY FLUTICASONE PROPIONATE, AND ONCE-DAILY MONTELUKAST ON BONE MINERAL DENSITY IN PATIENTS WITH MILD ASTHMA
    Maspero, J.
    Backer, V.
    Yao, R.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A41 - A41
  • [42] A comparison of twice daily and once-daily administration of fluticasone propionate cream, 0.05%, in the treatment of eczema
    Tharp, MD
    CUTIS, 1996, 57 : 19 - 26
  • [43] Randomized Trial of Once-Daily Fluticasone Furoate in Children with Inadequately Controlled Asthma
    Oliver, Amanda J.
    Covar, Ronina A.
    Goldfrad, Caroline H.
    Klein, Ryan M.
    Pedersen, Soren E.
    Sorkness, Christine A.
    Tomkins, Susan A.
    Villaran, Cesar
    Grigg, Jonathan
    JOURNAL OF PEDIATRICS, 2016, 178 : 246 - +
  • [44] Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 μG Versus Twice-Daily Fluticasone Propionate 250 μG in Adolescents and Adults with Persistent Asthma
    Tomlinson, Ryan
    Parks, Daniel
    Martin, Alan
    LUNG, 2017, 195 (05) : 571 - 574
  • [45] Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 µG Versus Twice-Daily Fluticasone Propionate 250 µG in Adolescents and Adults with Persistent Asthma
    Ryan Tomlinson
    Daniel Parks
    Alan Martin
    Lung, 2017, 195 : 571 - 574
  • [46] Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily
    Busse, W
    Koenig, SM
    Oppenheimer, J
    Sahn, SA
    Yancey, SW
    Reilly, D
    Edwards, LD
    Dorinsky, PM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (01) : 57 - 65
  • [47] Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
    Albertson, Timothy E.
    Bullick, Samuel W.
    Schivo, Michael
    Sutter, Mark E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 4047 - 4060
  • [48] Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) for 24 weeks in persistent asthma
    O'Byrne, Paul M.
    Bleecker, Eugene R.
    Bateman, Eric D.
    Busse, William W.
    Woodcock, Ashley
    Forth, Richard
    Toler, Tom
    Jacques, Loretta
    Lotvall, Jan
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [49] A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD
    Siler, Thomas M.
    Nagai, Atsushi
    Scott-Wilson, Catherine A.
    Midwinter, Dawn A.
    Crim, Courtney
    RESPIRATORY MEDICINE, 2017, 123 : 8 - 17
  • [50] Efficacy of combination fluticasone furoate/vilanterol (FF/VI) and salmeterol/fluticasone propionate (SFC) over 12 weeks in patients with COPD
    Agusti, Alvar
    De Backer, Wilfried
    de Teresa, Luis
    Zvarich, Michael
    Locantore, Nick
    Barnes, Neil
    Bourbeau, Jean
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345